Clinical Research Directory
Browse clinical research sites, groups, and studies.
Intrathecal Dexmedetomidine 5 mcg Versus 10 mcg With Bupivacaine for Infra-umbilical Surgery
Sponsor: Hussain Aziz Bhatti
Summary
This randomized controlled trial compares two isovolumetric intrathecal doses of dexmedetomidine (5 micrograms and 10 micrograms) added to 12.5 mg hyperbaric bupivacaine for spinal anaesthesia in adults undergoing elective infra-umbilical surgery. A total of 544 patients are randomly allocated into two groups of 272 each. The incidence of intraoperative hypotension is the primary outcome. Intraoperative bradycardia, number of hypotensive and bradycardic episodes, rescue drug use and time to two-segment regression of the sensory block are secondary outcomes.
Official title: Comparison of the Effect of Isovolumetric Intrathecal Adjuvant Doses of 5 μg and 10 μg Dexmedetomidine on Intraoperative Hemodynamics and Duration of Subarachnoid Block
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
544
Start Date
2025-08-01
Completion Date
2026-10-31
Last Updated
2026-11-10
Healthy Volunteers
No
Interventions
Dexmedetomidine 5 micrograms (intrathecal)
Dexmedetomidine 5 micrograms diluted with normal saline to 1 ml and added to 12.5 mg hyperbaric bupivacaine, injected intrathecally at L3-L4 or L4-L5 in the sitting position.
Dexmedetomidine 10 micrograms (intrathecal)
Dexmedetomidine 10 micrograms diluted with normal saline to 1 ml and added to 12.5 mg hyperbaric bupivacaine, injected intrathecally at L3-L4 or L4-L5 in the sitting position.
Hyperbaric bupivacaine 0.5%
12.5 mg (2.5 ml) of 0.5% hyperbaric bupivacaine given intrathecally in both groups.
Locations (1)
Department of Anaesthesia and Critical Care, Pakistan Institute of Medical Sciences
Islamabad, Islamabad, Pakistan